These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 582113)

  • 1. Lack of hypotensive and brain catecholamine depleting effects by erythro- and threo-alpha-methyl DOPS.
    Castellucci A; Bonacchi G; Bacciarelli C; Boni P
    Arzneimittelforschung; 1979; 29(1):27-31. PubMed ID: 582113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The stereoisomers of 3,4-dihydroxyphenylserine as precursors of norepinephrine.
    Bartholini J; Constantinidis J; Puig M; Tissot R; Pletscher A
    J Pharmacol Exp Ther; 1975 May; 193(2):523-32. PubMed ID: 1142103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Synthesis of norepinephrine from 3,4-dihydroxyphenylserine by L-aromatic amino acid decarboxylase of the rat brain and kidneys].
    Fujiwara H; Inagaki C; Ikeda Y; Tanaka C
    Nihon Yakurigaku Zasshi; 1976 Oct; 72(7):891-8. PubMed ID: 14060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal by L-threo-3,4-dihydroxyphenylserine (L-threo-DOPS), a L-norepinephrine precursor of reserpine- or tetrabenazine-induced hypothermia.
    Katsuyama M; Kato T; Karai N; Nakamura M; Katsube J
    Arch Int Pharmacodyn Ther; 1986 Sep; 283(1):61-70. PubMed ID: 3099671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of L-threo-3,4-dihydroxyphenylserine on efflux of monoamines and acetylcholine in guinea pig brain.
    Nishino N; Fujii Y; Kondo M; Shuntoh H; Fujiwara H; Tanaka C
    J Pharmacol Exp Ther; 1987 Aug; 242(2):621-8. PubMed ID: 3112367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DL-threo-DOPS as a precursor of noradrenaline.
    Reches A; Jackson-Lewis V; Fahn S
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov; 331(2-3):202-8. PubMed ID: 3937060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of L-threo-dihydroxyphenylserine on norepinephrine metabolism in rat brain.
    Semba J; Takahashi R
    Psychiatry Res; 1985 Aug; 15(4):319-26. PubMed ID: 3934694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibition of harmaline induced tremor by L-threo-3, 4-dihydroxyphenylserine, an L-norepinephrine precursor].
    Yamazaki M; Ikeda Y; Ishikawa M; Inagaki C; Tanaka C
    Nihon Yakurigaku Zasshi; 1976 Apr; 72(3):363-9. PubMed ID: 986992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of the reserpine-induced ptosis by L-threo-3,4-dihydroxy-phenylserine (L-threo-DOPS), a (-)-norepinephrine precursor, and its potentiation by imipramine or nialamide.
    Kato T; Katsuyama M; Karai N; Hirose A; Nakamura M; Katsube J
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Mar; 332(3):243-6. PubMed ID: 3086752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of L-threo-3,4-dihydroxyphenylserine(L-threo-DOPS) on brain and serum MHPG levels in mice: evidence for NE formation in CNS.
    Karai N; Kato T; Katsuyama M; Nakamura M; Katsube J
    Life Sci; 1987 Jun; 40(23):2261-8. PubMed ID: 3108598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of DL-erythro-dihydroxyphenylserine on the locomotor activity of the mouse.
    Mori T; Nakajima T; Hashimoto H; Noto T; Kato N
    Pharmacol Biochem Behav; 1985 Jun; 22(6):979-83. PubMed ID: 2862644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial attenuating effect of L-threo-3,4-dihydroxyphenylserine on postural hypotension in anesthetized rats.
    Satoh S; Oyabe A; Tanno M; Suzuki-Kusaba M
    Arzneimittelforschung; 1989 Sep; 39(9):1123-9. PubMed ID: 2511849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the activity of L-threo-3,4-dihydroxyphenylserine (L-DOPS) as a catecholamine precursor in the brain. Comparison with that of L-dopa.
    Kato T; Karai N; Katsuyama M; Nakamura M; Katsube J
    Biochem Pharmacol; 1987 Sep; 36(18):3051-7. PubMed ID: 3115271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diuretic effects of L-threo-3,4-dihydroxyphenylserine (L-threo-DOPS) in anesthetized rats.
    Morimoto S; Matsumura Y; Ohyama T; Shinyama H; Ichihara T; Takahashi Y; Hisaki K
    Jpn J Pharmacol; 1990 Mar; 52(3):431-9. PubMed ID: 2110272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of L-erythro-3, 4-dihydroxyphenylserine on sleep-wakefulness patterns and concentrations of brain catecholamines and serotonin in rats.
    Mori M; Hashimoto H; Fukui K; Mori T; Noto T; Nakajima T
    Jpn J Psychiatry Neurol; 1987 Jun; 41(2):301-10. PubMed ID: 3125374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase in norepinephrine turnover after tyrosine or DL-threo-3,4-dihydroxyphenylserine (DL-threo-DOPS).
    Gibson CJ
    Life Sci; 1988; 42(1):95-102. PubMed ID: 3121971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the central action of L-threo-3,4-dihydroxyphenyl-serine (L-threo-DOPS) in FLA-63-treated mice.
    Kato T; Katsuyama M; Karai N; Nakamura M; Katsube J
    Pharmacol Biochem Behav; 1987 Feb; 26(2):407-11. PubMed ID: 3106991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pressor effect of L-threo-3,4-dihydroxyphenylserine in rats.
    Araki H; Tanaka C; Fujiwara H; Nakamura M; Ohmura I
    J Pharm Pharmacol; 1981 Dec; 33(12):772-7. PubMed ID: 6121848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Formation of norapinephrine in the rat brain after administration of ((+)-erythro-3,4-dihydroxyphenylserine(author's transl)].
    Constantinidis J; Geissbuhler F; Gaillard JM; Aubert C; Hovaguimian TH; Tissot R
    Psychopharmacologia; 1975; 41(3):201-9. PubMed ID: 1153609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 3,4-dihydroxyphenylserine on the concentration of brain noradrenaline and the level of plasma growth hormone of rats.
    Hirai M; Matsuoka Y; Nakajima T; Sano I
    Med J Osaka Univ; 1975 Sep; 26(12):51-9. PubMed ID: 1228392
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.